Results 1 to 10 of about 168,097 (250)

Heart failure with preserved ejection fraction [PDF]

Annual Review of Medicine, 2018
Heart failure with preserved ejection fraction (HFpEF) represents a heterogeneous collection of conditions that are unified by the presence of a left ventricular ejection fraction ≥50%, evidence of impaired diastolic function and elevated natriuretic ...
Harper, Andrew, Lyon, AR, Patel, HC
core   +4 more sources

Spironolactone for heart failure with preserved ejection fraction [PDF]

New England Journal of Medicine, 2014
BACKGROUND: Mineralocorticoid-receptor antagonists improve the prognosis for patients with heart failure and a reduced left ventricular ejection fraction.
Anand, Inder S., Assmann, Susan F., Boineau, Robin, Claggett, Brian, Clausell, Nadine, Desai, Akshay S., Diaz, Rafael, Fleg, Jerome L., Gordeev, Ivan, Harty, Brian, Heitner, John F., Kenwood, Christopher T., Lewis, Eldrin F., McKinlay, Sonja M., O'Meara, Eileen, Pfeffer, Marc A., Pitt, Bertram, Probstfield, Jeffrey L., Shaburishvili, Tamaz, Shah, Sanjiv J., Solomon, Scott D., Sweitzer, Nancy K., TOPCAT Investigators, Ventura, H., Yang, Song   +24 more
core   +2 more sources

Heart Failure with Preserved Ejection Fraction [PDF]

Current Emergency and Hospital Medicine Reports, 2019
Heart failure with preserved ejection fraction (HFpEF), formerly known as diastolic heart failure, is a chronic disease that affects millions of people around the world.
Ryan, Abigalle
core   +4 more sources

Ventricular-arterial uncoupling in heart failure with preserved ejection fraction after myocardial infarction in dogs - invasive versus echocardiographic evaluation [PDF]

, 2010
Heart failure with preserved left ventricular ejection fraction and abnormal diastolic function is commonly observed after recovery from an acute myocardial infarction.
AC Smith, Bachar El Oumeiri, CM Yu, CY Lee, D Burkhoff, D Burkhoff, D Westermann, DA Kass, GI Galasko, Guy R Heyndrickx, I Ahmet, I Mirsky, Ielham Hadad, J Baan, J Häggström, J Neter, JA Glenski, JC Gilbert, JE Moller, Jozef Bartunek, JP Hellermann, K Dickstein, K Schwarz, K Seki, K Sunagawa, K Sunagawa, Karim Touihri, Kathleen Mc Entee, KL He, M Kasner, M Kawaguchi, Maryam Mahmoudabady, MM Lewinter, MR Zile, MR Zile, MS Maurer, Myrielle Mathieu, Philippe Thoma, Robert Naeije, S Motte, Serge Brimioulle, T Aoyagi, T Nozawa, TE Raya, Thierry Metens, WC Little, WJ Paulus, WP Thomas, Y Hori   +48 more
core   +5 more sources

One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction [PDF]

, 2016
Background—Heart failure with preserved ejection fraction has a complex pathophysiology and remains a therapeutic challenge. Elevated left atrial pressure, particularly during exercise, is a key contributor to morbidity and mortality.
Bergmann, Martin, Burkhoff, Dan, Doughty, Robert, Feldman, Ted, Hasenfuß, Gerd, Hausleiter, Jorg, Hayward, Christopher, Jondeau, Guillaume, Kaye, David M., Kolodziej, Adam, Muller, David, Neuzil, Petr, Penicka, Martin, Petrie, Mark C., Ponikowski, Piotr, Post, Martijn C., Raake, Philip, Rosenberg, Mark, Silvestry, Frank E., Trochu, Jean-Noël, van Veldhuisen, Dirk J., Walters, Darren, Walton, Antony, Westenfeld, Ralf   +23 more
core   +15 more sources

Heart failure with preserved ejection fraction – onset [PDF]

Българска кардиология, 2021
During these more than 20 years of evolution in understandings of the mechanisms of heart failure (HF) with preserved fractional ejection, there has been a rich variety of terminology, including „diastolic heart failure“, „heart failure with preserved ...
Branimir Kanazirev
doaj   +3 more sources

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction

Journal of Cardiovascular Development and Disease, 2023
(1) Background: Chronic inflammation and fibrosis are key players in cardiac remodeling associated with left ventricular hypertrophy (LVH) and heart failure with a preserved ejection fraction (HFpEF). Monocytes and T-helpers (Th) are involved in both pro-
Artem Ovchinnikov, Anastasiya Filatova, Alexandra Potekhina, Tatiana Arefieva, Anna Gvozdeva, Fail Ageev, Evgeny Belyavskiy   +6 more
doaj   +1 more source

Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine, 2022
BackgroundAlthough the predictive value of galectin-3 for heart failure with preserved ejection fraction has been demonstrated, the diagnostic value remains unclear.
Jing Jiang, Baojun Yang, Ying Sun, Jing Jin, Zhiying Zhao, Songming Chen   +5 more
doaj   +1 more source

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj   +1 more source

Diagnostic and prognostic implications of growth differentiation factor 15 in heart failure with preserved ejection fraction: a systematic review and meta-analysis. [PDF]

PeerJ
Dakota I, Wijayanto MA, Nugrahani ASD, Sunjaya AF, Rachmayanti S, Indah EY, Naomi N, Huang W, Tristan CD, Fauziah M, Muliawan HS, Siswanto BB.   +11 more
europepmc   +3 more sources